Skip to search formSkip to main contentSkip to account menu

lanthanum carbonate 500 MG Chewable Tablet [Fosrenol]

Known as: FOSRENOL 500 MG Chewable Tablet, LANTHANUM CARBONATE 500 mg ORAL TABLET, CHEWABLE [Fosrenol] 
National Institutes of Health

Related topics

Related topics

9 relations
Chewable TabletDextratesFosrenolLanthanum

Broader (1)

lanthanum carbonate 500 MG Chewable Tablet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
ARNI: Eine neues Wirkprinzip
ema der Konferenz waren Erkenntnisse zur Entstehung und erapie von Störungen des Mineralund Knochensto wechsels bei Patienten mit… 
2015
2015
Hypertone Salzlösung gegen Rhinosinusitis
ema der Konferenz waren Erkenntnisse zur Entstehung und erapie von Störungen des Mineralund Knochensto wechsels bei Patienten mit… 
2015
2015
Neues Fortbildungsformat etabliert sich
ema der Konferenz waren Erkenntnisse zur Entstehung und erapie von Störungen des Mineralund Knochensto wechsels bei Patienten mit… 
2014
2014
Pilot Study of the Effect of Lanthanum Carbonate (Fosrenol®) In Patients with Calciphylaxis: A Wisconsin Network for Health Research (WiNHR) Study
Background Currently there is a lack of effective treatment options for patients with calciphylaxis. There is anecdotal evidence… 
2014
2014
Chewability testing in the development of a chewable tablet for hyperphosphatemia
Abstract The official Pharmacopeia does not include a test procedure for the in vitro estimation of the chewability of tablets… 
2013
2013
Lanthanum-Carbonat (Fosrenol®)
Lanthanum-Carbonat bindet im sauren Milieu des Magens Phosphat (in vitro ca. 97%), so dass unlösliches, nicht resorbierbares… 
2011
2011
Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study
BackgroundLanthanum carbonate (FOSRENOL®) is an effective, well-tolerated phosphate binder. The ability of lanthanum to reduce… 
Review
2009
Review
2009
Lanthanum Carbonate
SummaryAbstractOrally administered lanthanum carbonate (Fosrenol®) dissociates in the acid environment of the upper… 
2008
2008
A Model of the Kinetics of Lanthanum in Human Bone, Using Data Collected during the Clinical Development of the Phosphate Binder Lanthanum Carbonate
AbstractObjective: Lanthanum carbonate (Fosrenol®) is a non-calcium phosphate binder that controls hyperphosphataemia without… 
2008
2008
Introducción al carbonato de lantano; farmacología, seguridad y tolerabilidad
Se describen varios aspectos de Fosrenol® (carbonato de lantano), que se pueden resumir como sigue: El lantano tiene gran… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)